Summary: Courthouse News provides an overview of Senate Bill 519 in California that would decriminalize the use and possession of certain psychedelics, mentioning the results of past MAPS-sponsored clinical trials of MDMA-assisted therapy for PTSD. “Drug decriminalization is a necessary first step to repairing the harms from the decades-long public health disaster of the War on Drugs,” says MAPS Policy and Advocacy Director Natalie Ginsberg, M.S.W., who served on a team at MAPS that supported the development of the bill.
Originally appearing here.
